1921
Volume 90, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

In the early 1980s, the antischistosomal aryl hydantoin Ro 13-3978 (AH01), a close structural analogue of the androgen receptor antagonist nilutamide, was discovered. Administration of 100 mg/kg oral doses of AH01 to mice infected with adult and juvenile produced 95% and 64% total worm burden reductions, confirming its high activity against adult worms, and showing that AH01 is also effective against juvenile infections. AH01 had no measureable interaction with the androgen receptor in a ligand competition assay, but it did block dihydrotestosterone-induced cell proliferation in an androgen-dependent human prostate cancer cell line. For AH01, nilutamide, and three closely related aryl hydantoin derivatives, there was no correlation between antischistosomal activity and androgen receptor interaction.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0029
2014-06-04
2017-09-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/90/6/1156.html?itemId=/content/journals/10.4269/ajtmh.14-0029&mimeType=html&fmt=ahah

References

  1. Caffrey CR, , 2007. Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11: 433439.[Crossref]
  2. Utzinger J, N'goran EK, Caffrey CR, Keiser J, , 2011. From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 120: S121S137.[Crossref]
  3. Gryseels B, , 2012. Schistosomiasis. Infect Dis Clin North Am 26: 383397.[Crossref]
  4. Olliaro P, Delgado-Romero P, Keiser J, , 2014. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J Antimicrob Chemother 69: 863870.[Crossref]
  5. Bernauer K, Link H, Stohler H, , 1980. Antiandrogenic and schistosomicidal imidazolidine derivatives. US Patent 4,234,736.
  6. Forget E, Félix H, Notteghem MJ, Léger N, , 1982. Appréciation de l'activité de dérivés schistosomicides en microscopie électronique. Bull Soc Pathol Exot 75: 192200.
  7. Hansen JB, Hafliger O, , 1983. Determination of the dissociation constant of a weak acid using a dissolution rate method. J Pharm Sci 72: 429431.[Crossref]
  8. Link H, Stohler HR, , 1984. 3-Arylhydantoine, eine substanzklasse mit schistosomizider wirkung. Eur J Med Chem 19: 261265.
  9. Keiser J, Vargas M, Vennerstrom JL, , 2010. Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice. J Antimicrob Chemother 65: 19911995.[Crossref]
  10. de Mendonça RL, Escrivá H, Bouton D, Laudet V, Pierce RJ, , 2000. Hormones and nuclear receptors in schistosome development. Parasitol Today 16: 233240.[Crossref]
  11. Battmann T, Bonfils A, Branche C, Humbert J, Goubet F, Teutsch G, Philibert D, , 1994. Ru 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsuitism. J Steroid Biochem Molec Biol 48: 5560.[Crossref]
  12. Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD, , 2009. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 52: 35973617.[Crossref]
  13. Féau C, Arnold LA, Kosinski A, Guy RK, , 2009. A high-throughput ligand competition binding assay for the androgen receptor and other nuclear receptors. J Biomol Screen 14: 4348.[Crossref]
  14. Igawa T, Lin FF, Lee MS, Karan D, Batra SK, Lin MF, , 2002. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate 50: 222235.[Crossref]
  15. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, Trapman J, Brinkmann AO, Mulder E, , 1992. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41: 665669.[Crossref]
  16. Olea N, Sakabe K, Soto AM, Sonnenschein C, , 1990. The proliferative effect of “anti-androgens” on the androgen-sensitive human prostate tumor cell line LNCaP. Endocrinology 126: 14571463.[Crossref]
  17. De Launoit Y, Veilleux R, Dufour M, Simard J, Labrie F, , 1991. Characteristics of the biphasic action of androgens and the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells. Cancer Res 51: 51655170.
  18. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E, , 1992. Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31: 23932399.[Crossref]
  19. Georget V, Térouanne B, Nicolas J-C, Sultan C, , 2002. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry 41: 1182411831.[Crossref]
  20. Fantappié MR, Galina A, de Medonca RL, Furtado DR, Secor WE, Colley DG, Corrêa-Oliveira R, Freeman G, Jr Tempone AJ, de Camargo LL, Rumjanek FD, , 1999. Molecular characterization of a NADH ubiquinone oxidoreductase subunit 5 from Schistosoma mansoni and inhibition of mitochondrial respiratory chain function by testosterone. Mol Cell Biochem 202: 149158.[Crossref]
  21. Morales-Montor J, Mohamed F, Ghaleb AM, Baig S, Hallal-Calleros C, Damian RT, , 2001. In vitro effects of hypothalamic-pituitary-adrenal axis (HPA) hormones on Schistosoma mansoni . J Parasitol 87: 11321139.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0029
Loading
/content/journals/10.4269/ajtmh.14-0029
Loading

Data & Media loading...

  • Received : 13 Jan 2014
  • Accepted : 07 Mar 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error